Review
Neoantigens in cancer immunotherapy
- 1Division of Immunology, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, Netherlands.
- 2Department of Pathology and Immunology, Washington University School of Medicine, 660 South Euclid Avenue, St. Louis, MO 63110, USA.
- ↵*Corresponding author. E-mail: t.schumacher{at}nki.nl (T.N.S.); schreiber{at}immunology.wustl.edu (R.D.S.)
See allHide authors and affiliations
Science 03 Apr 2015:
Vol. 348, Issue 6230, pp. 69-74
DOI: 10.1126/science.aaa4971
Vol. 348, Issue 6230, pp. 69-74
DOI: 10.1126/science.aaa4971
Ton N. Schumacher
1Division of Immunology, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, Netherlands.
Robert D. Schreiber
2Department of Pathology and Immunology, Washington University School of Medicine, 660 South Euclid Avenue, St. Louis, MO 63110, USA.